7-((1R,2R,3R)-2-(4,4-Difluoro-3-oxooctyl)-3-hydroxy-5-oxocyclopentyl)heptanoic acid, 98%, 25mg

Monohidrato de ácido gálico, mínimo 98 %, pa, ACS, 100 g, envase de plástico.

5,7-Dichloro-3-methyl-3H-imidazo[4,5-b]pyridine, 95%, 1g

1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide, 95.0%, 10g

5-Fluoro-6-methoxy-1H-indole, 95.0%, 1g

6-Methyl-2-pyridinecarboxaldehyde>98.0%(GC)5g

(5-Bromopyridin-3-yl)(pyrrolidin-1-yl)methanone, 95.0%, 1g

2-Amino-4,6-dichloropyrimidine>98.0%(N)25g

Ruthenium(III) acetylacetonate, 99.0%, 25g

1,2,3,3-Tetramethyl-3H-indol-1-ium iodide, 95.0%, 10g

1-(4-Methoxyphenyl)-3-oxocyclobutane-1-carboxylic acid, 95+%, 5g

3-(4-PIPERIDINYL)-2(1H)-QUINOLINONE HYDROCHLORIDE, 95%, 25g

Tert-butyl 4-((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)carbamoyl)piperazine-1-carboxylate, 98%, 250mg